Signal_NN
transducer_NN
and_CC
activator_NN
of_IN
transcription-3_NN
-LRB-_-LRB-
STAT3_NN
-RRB-_-RRB-
is_VBZ
constitutively_RB
activated_VBN
in_IN
normal_JJ
,_,
self-renewing_JJ
B-1_NN
cells_NNS
but_CC
only_RB
inducibly_RB
expressed_VBN
in_IN
conventional_JJ
B_NN
lymphocytes_NNS
-LCB-_-LRB-
see_VB
comments_NNS
-RCB-_-RRB-

Cytokine_NN
and_CC
growth_NN
factor_NN
receptor_NN
engagement_NN
leads_VBZ
to_TO
the_DT
rapid_JJ
phosphorylation_NN
and_CC
activation_NN
of_IN
latent_JJ
,_,
cytosolic_JJ
signal_NN
transducers_NNS
and_CC
activators_NNS
of_IN
transcription_NN
-LRB-_-LRB-
STAT_NN
-RRB-_-RRB-
proteins_NNS
,_,
which_WDT
then_RB
translocate_VBP
to_TO
the_DT
nucleus_NN
where_WRB
they_PRP
regulate_VBP
transcriptional_JJ
events_NNS
from_IN
specific_JJ
promoter_NN
sequences_NNS
._.

STAT3_NN
expression_NN
in_IN
particular_JJ
has_VBZ
been_VBN
associated_VBN
with_IN
Abl_NN
,_,
Src_NN
,_,
and_CC
HTLV-1_NN
transformation_NN
of_IN
normal_JJ
cells_NNS
._.

B-1_NN
lymphocytes_NNS
are_VBP
self-renewing_JJ
,_,
CD5_NN
+_CC
B_NN
cells_NNS
that_WDT
display_VBP
a_DT
propensity_NN
for_IN
malignant_JJ
transformation_NN
and_CC
are_VBP
the_DT
normal_JJ
counterpart_NN
to_TO
human_JJ
chronic_JJ
lymphocytic_JJ
leukemias_NNS
._.

Further_RB
,_,
B-1_NN
cells_NNS
are_VBP
characterized_VBN
by_IN
aberrant_JJ
intracellular_JJ
signaling_NN
,_,
including_VBG
hyperresponsiveness_NN
to_TO
phorbol_NN
ester_NN
PKC_NN
agonists_NNS
._.

Here_RB
we_PRP
demonstrate_VBP
that_IN
B-1_NN
lymphocytes_NNS
constitutively_RB
express_VBP
nuclear_JJ
activated_VBN
STAT3_NN
,_,
which_WDT
is_VBZ
not_RB
expressed_VBN
by_IN
unmanipulated_JJ
conventional_JJ
-LRB-_-LRB-
B-2_NN
-RRB-_-RRB-
lymphocytes_NNS
._.

In_IN
contrast_NN
,_,
STAT3_NN
activation_NN
is_VBZ
induced_VBN
in_IN
B-2_NN
cells_NNS
after_IN
antigen_NN
receptor_NN
engagement_NN
in_IN
a_DT
delayed_VBN
fashion_NN
-LRB-_-LRB-
after_IN
3_CD
h_NN
-RRB-_-RRB-
._.

Induction_NN
of_IN
STAT3_NN
is_VBZ
inhibited_VBN
by_IN
both_CC
the_DT
serine\/threonine_NN
protein_NN
kinase_NN
inhibitor_NN
H-7_NN
and_CC
the_DT
immunosuppressive_JJ
drug_NN
rapamycin_NN
and_CC
requires_VBZ
de_FW
novo_FW
protein_NN
synthesis_NN
,_,
demonstrating_VBG
novel_JJ
coupling_NN
between_IN
sIg_NN
and_CC
STAT_NN
proteins_NNS
that_WDT
differs_VBZ
from_IN
the_DT
classical_JJ
paradigm_NN
for_IN
STAT_NN
induction_NN
by_IN
cytokine_NN
receptors_NNS
._.

The_DT
inability_NN
of_IN
prolonged_JJ
stimulation_NN
of_IN
conventional_JJ
B-2_NN
cells_NNS
with_IN
anti-Ig_NN
,_,
a_DT
treatment_NN
sufficient_JJ
to_TO
induce_VB
CD5_NN
expression_NN
,_,
to_TO
result_VB
in_IN
sustained_JJ
STAT3_NN
activation_NN
suggests_VBZ
that_IN
STAT3_NN
is_VBZ
a_DT
specific_JJ
nuclear_JJ
marker_NN
for_IN
B-1_NN
cells_NNS
._.

Thus_RB
,_,
STAT3_NN
may_MD
play_VB
a_DT
role_NN
in_IN
B_NN
cell_NN
antigen-specific_JJ
signaling_NN
responses_NNS
,_,
and_CC
its_PRP$
constitutive_JJ
activation_NN
is_VBZ
associated_VBN
with_IN
a_DT
normal_JJ
cell_NN
population_NN
exhibiting_VBG
intrinsic_JJ
proliferative_JJ
behavior_NN
._.

